HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 243 filers reported holding HORIZON PHARMA PLC in Q4 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,200,000 | -1.9% | 83,225 | -27.5% | 0.01% | -14.3% |
Q4 2018 | $2,243,000 | -14.4% | 114,802 | -14.2% | 0.01% | 0.0% |
Q3 2018 | $2,619,000 | -9.0% | 133,754 | -23.1% | 0.01% | -22.2% |
Q2 2018 | $2,879,000 | +9.2% | 173,877 | -6.4% | 0.02% | +5.9% |
Q1 2018 | $2,637,000 | +40.4% | 185,684 | +44.4% | 0.02% | +41.7% |
Q4 2017 | $1,878,000 | +15.4% | 128,606 | +0.2% | 0.01% | +9.1% |
Q3 2017 | $1,627,000 | +25.7% | 128,348 | +17.8% | 0.01% | +37.5% |
Q2 2017 | $1,294,000 | +5.6% | 108,994 | +31.5% | 0.01% | +14.3% |
Q1 2017 | $1,225,000 | +171.6% | 82,883 | +197.1% | 0.01% | +250.0% |
Q4 2016 | $451,000 | +132.5% | 27,898 | +161.3% | 0.00% | +100.0% |
Q3 2016 | $194,000 | +10.2% | 10,677 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $176,000 | – | 10,677 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,018,021 | $44,063,000 | 7.20% |
SCOPIA CAPITAL MANAGEMENT LP | 16,370,364 | $239,007,000 | 4.29% |
JW Asset Management, LLC | 270,775 | $3,953,000 | 4.21% |
Avoro Capital Advisors LLC | 4,436,183 | $64,768,000 | 4.20% |
Rhenman & Partners Asset Management AB | 1,954,912 | $28,542,000 | 3.86% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,341,894 | $92,592,000 | 3.64% |
Paulson & Co. | 7,870,700 | $114,912,000 | 2.24% |
Proxima Capital Management, LLC | 260,000 | $3,796,000 | 2.20% |
KOPP INVESTMENT ADVISORS LLC | 105,126 | $1,535,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 1,000,000 | $14,600,000 | 1.46% |